This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Wei Tong - Innovator in Pharmaceutical Development
Introduction
Wei Tong is a notable inventor based in New City, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of erectile dysfunction. His innovative work has led to the development of a unique metabolite that has potential therapeutic applications.
Latest Patents
Wei Tong holds a patent for a metabolite of a xanthine Phosphodiesterase type 5 inhibitor. This invention is particularly useful for the treatment of erectile dysfunction. The patent outlines the structure of the metabolite, its derivatives, and formulations, as well as processes for preparing the compound. Furthermore, it discloses methods for treating various physiological disorders, including urogenital, cardiovascular, and cerebrovascular disorders, among others. This patent represents a significant advancement in the treatment options available for patients suffering from these conditions. Wei Tong has 1 patent to his name.
Career Highlights
Wei Tong is associated with Schering Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a broader impact on healthcare.
Collaborations
Wei Tong has collaborated with notable colleagues, including Anima Ghosal and Swapan K Chowdhury. These partnerships have fostered innovation and have been crucial in the development of new therapeutic solutions.
Conclusion
Wei Tong's contributions to the field of pharmaceuticals, particularly through his patent for a metabolite of a xanthine Phosphodiesterase type 5 inhibitor, highlight his role as an innovator. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
